HI-6 Dimethanesulfonate (DMS) and Atropine Sulfate Reconstitution Autoinjector Device (RAD) Feasibility Assessment
Department of National Defence (DND) · Ottawa, Ontario, Canada
Time Left to Bid
Closed
Basic information
- Reference number
- W6369-26-A112
- Issuing organization
- Department of National Defence (DND) · Find award history →
- Government level
- Federal
- Solicitation type
- Professional & Consulting Services
- Title
- HI-6 Dimethanesulfonate (DMS) and Atropine Sulfate Reconstitution Autoinjector Device (RAD) Feasibility Assessment
- Source
- CanadaBuys
- Source ID
- W6369-26-A112
Details
- Location
- Ottawa, Ontario, Canada
Description
The Department of National Defence (DND), specifically the Canadian Forces Health Services (CFHS), has a requirement for the services of a Contractor to test and evaluate the feasibility of manufacturing HI-6 DMS and atropine sulfate drug products in a reconstitution autoinjector device (RAD). The scope of this requirement is to conduct a feasibility assessment using an existing prototype of a RAD with the configuration of HI-6 DMS in the dry chamber (500 mg +/- 25%) and 1 mL atropine (2 mg/mL)...
Dates
- Publication
- 2026/06/02 12:00:00 AM UTC
- Closing date
- 2026/06/16 02:00:00 PM UTC
Documents
acan---w6369-26-a112---hi-6-dms-and-atropine-rad-feasibility-assessment.pdf
External link
acan---w6369-26-a112---hi-6-dms-and-atropine-rad-feasibility-assessment_0.pdf
External link
pac---w6369-26-a112---evaluation-de-faisabilite-de-dar-dhi-6-dms-et-de-medicaments-a-base-de-sulfate-datropine.pdf
External link
pac---w6369-26-a112---evaluation-de-faisabilite-de-dar-dhi-6-dms-et-de-medicaments-a-base-de-sulfate-datropine_0.pdf
External link
How to bid
Classification
UNSPSC categories
Normalized category